María Reviejo

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 2

Top Topics

Combination Therapy

Systematic Review

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Top Venues

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Tania Payo-Serafín, Carolina Méndez-Blanco, Paula Fernández-Palanca, Jennifer Martínez-Geijo, María Reviejo, Juan José Ortiz-de-Urbina, Javier Gonzalez-Gallego, Jose J G Marin, José Luis Mauriz, Beatriz San-Miguel
Risk versus Benefit of Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Clinical pharmacology and therapeutics 116 (2) (2024)
Tania Payo-Serafín, Carolina Méndez-Blanco, Paula Fernández-Palanca, Jennifer Martínez-Geijo, María Reviejo, Juan José Ortiz-de-Urbina, Javier Gonzalez-Gallego, Jose J G Marin, José Luis Mauriz, Beatriz San-Miguel
Risk versus Benefit of Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Clinical pharmacology and therapeutics (2024)